Articles publiés

Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels

Largeau B, Karam A, Potey C, Caous AS, Tard C, Carton L, Kuchcinski G, Gautier S, Deheul S, Bordet R. Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels. Eur J Neurol. 2022 Apr 23. doi: 10.1111/ene.15370. Epub ahead of print. PMID: 35460312.

Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels Lire la suite »

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior

Laforgue EJ, Istvan M, Schreck B, Mainguy M, Jolliet P, Grall-Bronnec M, Victorri-Vigneau C. Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior. J Clin Med. 2022 Apr 13;11(8):2176. doi: 10.3390/jcm11082176. PMID: 35456269; PMCID: PMC9032177.

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior Lire la suite »

Increase of high-risk tramadol use and harmful consequences in France from 2013-2018: evidence from the triangulation of addictovigilance data.

Roussin A, Soeiro T, Fouque C, Jouanjus E, Frauger E, Fouilhé N, Mallaret M, Micallef J, Lapeyre-Mestre M; French Addictovigilance Network (FAN).  Br J Clin Pharmacol. 2022 Mar 22. doi: 10.1111/bcp.15323. Epub ahead of print. PMID: 35318713.

Increase of high-risk tramadol use and harmful consequences in France from 2013-2018: evidence from the triangulation of addictovigilance data. Lire la suite »

Transcultural validation of a French-European version of the Prescription Opioid Misuse Index Scale (POMI-5F)

Delage N, Cantagrel N, Delorme J, Pereira B, Dualé C, Bertin C, Chenaf C, Kerckhove N, Laporte C, Picard P, Roussin A, Authier N. Can J Anaesth. 2022 Feb 28. English. doi: 10.1007/s12630-022-02210-7. Epub ahead of print. PMID: 35229249.

Transcultural validation of a French-European version of the Prescription Opioid Misuse Index Scale (POMI-5F) Lire la suite »

Ketamine use in outpatients: What can we learn from current practices?

Salvati A, Daveluy A, Clavery R, Miremont-Salamé G, Micallef J, Frauger É; Réseau français d’addictovigilance. Utilisation de la kétamine chez les patients ambulatoires : que pouvons-nous apprendre des pratiques actuelles ? Therapie. 2022 Jan 24:S0040-5957(22)00013-0. French. doi: 10.1016/j.therap.2022.01.011. Epub ahead of print. PMID: 35172927.

Ketamine use in outpatients: What can we learn from current practices? Lire la suite »

Retour en haut